Targeting the lipid desaturation network in cancer: from metabolic plasticity to precision therapeutics
Justyna J Gleba, John A Copland, Han W Tun · 2026
Read Targeting the lipid desaturation network in cancer: from metabolic plasticity to precision therapeutics by Justyna J Gleba, John A Copland, Han W Tun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13508349.txt.
Description
Justyna Gleba, John Copland, and Han Tun review how cancers rewire fat chemistry to survive, and how that wiring could become a drug target, in 2026 work. Cells soften fats by adding double bonds, a step called desaturation, which keeps membranes fluid. Two enzyme routes run this work. Tumors lean on the first route to dodge toxic fat buildup and a form of iron-driven cell death. The second route is a paradox: it feeds growth signals yet loads membranes with fats that make that same cell death easier to trigger.
Drug hunters are now testing blockers of the first enzyme, with one candidate in an early human trial for solid tumors. Tumors fight back through a side shunt that restores soft fats, driving resistance. The review maps combination ideas pairing these blockers with diet changes, other drugs, and smart delivery systems to corner the workaround.
Catalog record
| CREATOR | Justyna J Gleba, John A Copland, Han W Tun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61046 |
| LICENSE | https://creativecommons.org/publicdomain/zero/1.0 |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |